Category : Search result: obesity research


Ozempic and Mounjaro Could Raise UK Pension Age

Experts warn that the widespread use of obesity drugs like Ozempic and Mounjaro could extend life expectancy, potentially pushing the UK government to raise the state pension age sooner than expected.

Mounjaro Weight Loss Jab Approved in UK

The UK approves Mounjaro, a groundbreaking weight loss injection, but concerns over its £300 monthly price tag spark debate over NHS accessibility.

NHS to offer weight loss drug Mounjaro

The NHS is set to provide the groundbreaking weight loss medication Mounjaro, produced by Eli Lilly, following successful trials. Shadow Science Secretary Peter Kyle urges swift government action to tackle obesity.

Half of UK dogs dangerously overweight

A new report warns that over 50% of dogs in the UK are overweight, putting them at risk of serious health issues. Experts share tips on proper pet nutrition and exercise.

Eli Lilly developing weight loss pill to rival injections

Pharmaceutical giant Eli Lilly is developing an oral weight loss drug that may compete with injectable treatments like Wegovy. Early trials show promising results, potentially offering a more convenient alternative for patients.

UK chip eaters risking health, study warns

A new study reveals that frequent chip consumption may lead to serious health risks, including heart disease and obesity. Experts weigh in on healthier alternatives.

How I lost 3 stone with weight loss jabs

A woman shares her inspiring journey of losing 3 stone with the help of weight loss injections, revealing the challenges and triumphs along the way.

Page 1 of 4